1. Introduction {#sec1}
===============

Cardiovascular disease (CVD) describes various conditions that affect the functioning of heart/cardiovascular \[[@B1]\]. Due to the high rate of disease morbidity, CVD has become the leading cause of mortality around the world \[[@B2]--[@B4]\]. In New Zealand, statistics on CVD mortality in 2017 suggests that the percentage of deaths caused by CVD is 33% \[[@B4]\].

Majority of cardiovascular-related deaths are premature and preventable and can be improved by effective health management by employing effective diet plans, lifestyle interventions, and drug intervention \[[@B5]\]. To prevent CVD, a useful approach is to assess CVD risk regularly and then introduce new lifestyle adjustments or clinical treatments accordingly.

In the past decades, a great deal of research has been done on the CVD risk estimation such as the Framingham risk scores from the Framingham Heart Study (FHS) \[[@B6], [@B7]\], the QRISK equations \[[@B8]\], the Europe SCORE risk equations \[[@B9]\], the ASSIGN scores from the Scottish Heart Health Extended Cohort (SHHEC) \[[@B10]\], the Prospective Cardiovascular Master (PROCAM) equations \[[@B11]\], and the CUORE Cohort Study formulas \[[@B12]\]. These CVD risk prediction models have proved their effectiveness in the health and disease management for clinicians and individuals \[[@B13]--[@B15]\]. The new PREDICT CVD risk assessment equation developed for primary health care among the population in New Zealand has been integrated to the electronic health records (EHRs) and a web-based software called PREDICT has been developed to support general practices manage the CVD risk in primary care \[[@B13]\]. The PREDICT has got 400,728 patients assessed with the CVD risk and is becoming a useful tool for decision support and health management for general practitioners.

However, challenges and issues regarding the development of CVD risk estimation models still exist. CVD risk models \[[@B16]--[@B18]\] are based on single risk factor which cannot realize the influence of multiple factors simultaneously. Risk models \[[@B6], [@B8], [@B19]\] using statistical regression methods \[[@B20]--[@B22]\] prefer to use classic risk factors such as age, smoking, diabetes, sex, high blood pressure, and total cholesterol to estimate the risk score. Studies \[[@B18], [@B19], [@B23]--[@B27]\] applying data mining or machine learning techniques for the CVD risk estimations cannot provide an absolute risk estimation, although some of these models \[[@B18], [@B26]\] tried to incorporate novel predictors in the risk models. This research aims to identify the novel risk factors for CVD detection by conventional predictors and then enhance the risk estimation by developing a multiple-variable-based risk prediction model that targets the 5-year and 10-year CVD events.

2. Methods {#sec2}
==========

2.1. Study Population {#sec2.1}
---------------------

The study population selected from the Framingham Original Cohort study dataset \[[@B28], [@B29]\]. We obtained the ethics approval from NHLBI \[[@B30]\] and the Auckland University of Technology Ethics Committee (AUTEC) (Ref: 17/385 Early Detection and Self-Management of Cardiovascular Disease Using Artificial Intelligence-Based Model). The data from this cohort study includes a total of 5079 men and women aged 30-74 years free of CVD at the baseline, of them 3189 had CVD events eventually. Details of the CVD events distribution in male and female among the study population are summarized in [Table 1](#tab1){ref-type="table"}.

2.2. Data Extraction {#sec2.2}
--------------------

There are 32 exams in the Framingham Original Cohort study dataset, as shown in [Appendix A](#secA){ref-type="sec"}. Data frame collected in the first exam "Exam1" was chosen to develop the CVD prediction model because it has the maximum number of samples 5209 subjects. Data from 130 subjects were removed because of the ethics protection. The other five exams are ranging from 8 to 12, marked with italic font (as shown in [Table 7](#tab7){ref-type="table"} of [Appendix A](#secA){ref-type="sec"}) and will be used for the validation for the fitted model. Data of candidate risk factors (listed in [Table 2](#tab2){ref-type="table"}) for creating the risk model was extracted.

2.3. Statistical Analysis {#sec2.3}
-------------------------

Cox proportional hazard regression analysis \[[@B22]\] was selected for developing the proposed risk model (one of the most accurate method belonging to the semiparametric statistical method). This research aims to develop a prediction model using multiple parameters to estimate the probability of developing CVD for an individual. There are mainly three statistical approaches in*survival analysis*, i.e., nonparametric, semiparametric, and parametric \[[@B31]\]. The nonparametric approaches can only perform univariate analysis with single predictor and therefore are not suitable for the study of continuous variables \[[@B22], [@B32]\]. Both parametric and semiparametric approaches can perform multiple parameter analysis. They assume that the predictors and the log hazard rate have a linear relationship between \[[@B33]\]. However, the Cox proportional hazard model has an advantage that only the rank orderings of the failure and censoring times are used to estimate and test the regression coefficients \[[@B22]\]. The Cox model is more efficient even though the assumption of the parametric models is met. When the assumptions are not met, the Cox regression analysis can still be used efficiently with an extended Cox regression from \[[@B34]\], but a parametric model such as Weibull survival distribution would be a null model.

Statistical analyses were performed in R Studio platform \[[@B35]\]. Missing values for candidate risk factors listed in [Table 2](#tab2){ref-type="table"} were imputed using*Multiple Imputation* \[[@B36]\]. Continuous and categorical variables were transformed and imputed using algorithms modified from Maximum Generalized Variance (MGV) in the SAS PRINQUAL procedure \[[@B37]\]. R function*transcan* inside the "Hmisc" package was used \[[@B35]\].

For candidate predictors listed in [Table 2](#tab2){ref-type="table"}, two steps of variables selection from the list were performed. The first step was conducted in a "Forward Selection" manner \[[@B38]\]; i.e., the univariate Cox analysis was applied to all candidate variables. Insignificant predictors were filtered out based on a significance level p value \>0.05. In the second step, all selected variables from the univariate analysis were entered into the multivariate Cox regression analysis to see how the risk factors jointly impact the incidence rate for CVD. Risk factors with a p value less than 0.05 will be finally decided.

In the validation stage, two approaches were undertaken to assess the predictive ability of our fitted model, statistical validation, and empirical validation. The statistical validation was performed with respect to both discrimination and calibration. The empirical validation was defined as an empirical comparison with a general CVD risk prediction model (the Framingham office-based risk equation \[[@B6]\]) in a horizontal and longitudinal perspective. The horizontal comparison was conducted by comparing with the Framingham prognostic model using data collected from multiple samples at the same time point. The longitudinal comparison was conducted by comparing with the Framingham prognostic model using data collected from specific examples at different time-points (fixed time intervals follow-up) and seeing the risk trend for an individual over time.

3. Results {#sec3}
==========

3.1. Derivation of a 10-Year Risk Score for CVD {#sec3.1}
-----------------------------------------------

Risk factors included in the risk model are age, sex, body mass index (BMI), hypertension, systolic blood pressure (SBP), cigarettes per day, pulse rate, the status of diabetes. Characteristics of risk factors were listed in [Table 3](#tab3){ref-type="table"}. Statistics of "Min.", "1st Qu.", "Median", "Mean", "3rd Qu.", and "Max." of these risk factors are summarized.

The regression coefficients, hazard ratios, and their corresponding upper and lower 95% confidence intervals (CI) were estimated, as presented in [Table 4](#tab4){ref-type="table"}. Values of the baseline hazard rate where the time point is ten years were estimated as well, shown in [Table 5](#tab5){ref-type="table"}. The 10-year baseline hazard rate is 0.1023354 at mean values of all covariates, 0.001863652 at all covariates equal to zero. Corresponding, the survival probability (exp⁡(*basehaz*)) is 0.9027267 at mean values and 0.9981381 at all covariates equal to zero.

The Cox model has an exponential form (see Equation ([1](#EEq1){ref-type="disp-formula"})), where t represents the time that the event occurs; *λ*(*t*) is the hazard function for a subject at time t, determined by a set of m covariates (*X*~1~, *X*~2~,..., *X*~*k*~); *β*~1~, *β*~2~,...*β*~*k*~ are the regression coefficients that measure the effect size of covariates; exp is the exponential function (exp⁡(X) = ex); *λ*~0~(*t*) is the baseline hazard rate, an arbitrary (unknown) function, corresponding to the value of the hazard when all *X*~*i*~ equal zero.$$\begin{matrix}
{\lambda\left( { t} \right) = \lambda_{0}\left( { t} \right){\exp\left( {\beta_{1}X_{1} + \beta_{2}X_{2} + \ldots + \beta_{k}X_{k}} \right)}} \\
\end{matrix}$$

So, the Cox model can be written as a survival function:$$\begin{matrix}
{S\left( { t} \right) = \left\lbrack { S_{0}\left\lbrack { t} \right\rbrack} \right\rbrack^{\exp{({{\sum_{i = 1}^{k}\beta_{i}}X_{i}})}}} \\
\end{matrix}$$

A general formula for computing risk estimates has the following form:$$\begin{matrix}
{\hat{H\left( t \right)} = 1 - \left\lbrack { S_{0}\left\lbrack { t} \right\rbrack} \right\rbrack^{\exp{({{\sum_{i = 1}^{k}{\beta_{i}X_{i}}} - {\sum_{i = 1}^{k}{\beta_{i}{\overset{-}{X}}_{i}}}})}}} \\
\end{matrix}$$

where H(t) is the CVD risk estimated for an individual; S0(t) is baseline survival rate at follow-up time t, where t = 10 years (see [Table 5](#tab5){ref-type="table"}), *β*i is the regression coefficient (see [Table 4](#tab4){ref-type="table"}), *X*~*i*~ is the value of the *i*~*th*~ risk factor (if is continuous it is the log-transformed value), ${\overset{-}{X}}_{i}$is the corresponding mean, and k denotes the number of risk factors. The CVD risk function could be derived from ([3](#EEq3){ref-type="disp-formula"}), using regression coefficients from [Table 4](#tab4){ref-type="table"} and the baseline hazard rates from [Table 5](#tab5){ref-type="table"}; hence, we computed the probability of developing any type of CVD for an individual. A case of computing the absolute risk score in 10 years was demonstrated in [Appendix C](#secC){ref-type="sec"}.

3.2. Nomograms {#sec3.2}
--------------

A nomogram is a two-dimensional diagram to represent a mathematical function involving several predictors \[[@B39]\]. It is a simple graphical illustration to approximately predict a particular event based on conventional statistical regression methods such as Cox proportional hazards model for survival analysis \[[@B40]\]. A nomogram is accomplishing the estimation of individual survivals in 10 years and the median survival time by years was depicted in [Figure 1](#fig1){ref-type="fig"}.

In [Figure 1](#fig1){ref-type="fig"}, each predictor has a set of n scales, and there is a mapping between each scale and the "Points" scale. The bottoms are the corresponding 10-year survival estimates, and the median survival time (years). By accumulating the total points corresponding to the specific configuration of covariates for a patient, a clinician can then manually obtain the predicted value of the event for that patient.

3.3. Validation {#sec3.3}
---------------

The validation of the proposed predictive risk model was performed using traditional statistics. C-index (also called receiver operating characteristic (ROC) area) \[[@B41]\] was used to assess the goodness of the risk model based on a bootstrap internal resampling validation. From the statistical validation analysis, we got a C-index (area under the receiver operator curve \[AUROC\]) of 0.71 indicating moderately good discrimination.

Then, we performed an empirical validation by comparing our risk model with the Framingham Heart Study model in an external dataset horizontally and longitudinally over time. In the horizontal validation process, there were 2786 samples in the external dataset, and 1693 samples have got a CVD event. Risk scores using the FHS model and the proposed risk model were computed separately. Statistics of*min (lower whisker)*,*1st quartile (the lower hinge)*,*median*,*3rd quartile (the upper hinge)*, and*max (the extreme of the upper whisker)*of estimated risks for all samples are depicted in [Figure 2](#fig2){ref-type="fig"}. This box-whisker graph in [Figure 2](#fig2){ref-type="fig"} shows that the risks assessed by our Cox model are higher than the risk calculated by the Framingham model, but the error for five statistics (min, 1st Qu, median, mean, 3rd Qu., max) is within 0.02. For example, the median values of the FHS model and the Cox model are 0.1429475 and 0.1661985, respectively. For subjects with CVD event, the Cox model is much more accurate than the FHS model whereas for subjects without CVD, the Cox risk model overestimates the risk rate. Overall, the risk scale of the Cox model is consistent with the Framingham model, which highlights that the proposed Cox model is par with the FHS model.

In the longitudinal validation process, we selected four sex-specific subjects with or without CVD at the end of the Framingham Study. A summary of these four subjects is listed in [Table 6](#tab6){ref-type="table"} to confirm the longitudinal validation of the predicted CVD event.

For each sample, data with fixed time intervals (approximately two years) from longitudinal time follow-up are extracted. The data from five exams (Exam 8, Exam 9, Exam 10, Exam 11, and Exam 12) are extracted for comparison. Data summary for sample 1, sample 2, sample 3, and sample 4 are listed in [Appendix B](#secB){ref-type="sec"}. For each sample, the risks of developing CVD in 10 years related to the selected five exams data are separately computed using the Cox model and the Framingham model. Then the trend of risk over the years with 5% error is depicted, as shown in [Figure 3](#fig3){ref-type="fig"}. This figure shows that the trend of risks of these two models are consistent and risks for a specific sample increase over time, the dotted trend lines in each graph represent the increase in the CVD risk over time. Also, samples (both male and female) with diabetes that developed CVD will have a higher risk than the ones with no developed CVD.

4. Discussion {#sec4}
=============

It is widely accepted that CVD has become one of the significant public health issue globally \[[@B42], [@B43]\] and contributes significantly to the annual deaths globally. Previous studies have noted the importance of identifying associated risk factors and the early detection and intervention of CVDs \[[@B44]--[@B48]\] and investigated reducing the risk of developing CVD in early stages. Consequently, CVD risk prediction tools based on a single variable or multiple variables have been devised to yield estimates of the CVD risk \[[@B6], [@B8], [@B9], [@B14], [@B49]--[@B51]\].

Motivated by the objective of early detection and risk estimation of CVD, the present study was designed to identify novel CVD risk factors, determine the effect of these factors, and then develop a risk prediction model based on the identified factors. Although risk factors could vary from one specific CVD component to another, there is sufficient evidence that different types of CVD have commonalities of risk factors. We developed and validated a 10-year risk equation for CVD risk using follow-up data rigorously measured by the Framingham Heart Study.

This investigation extends the number of risk factors by the previous general CVD risk formulations, incorporating heart rate to estimate absolute CVD risk. The approach used in this research is based on advanced statistical techniques that allow reducing the bias in the assessment of true CVD risk. The whole process of data analysis strictly follows the guideline of regression modelling strategies and survival analysis \[[@B34], [@B52]\].

We use continuous variables (age, BMI, SBP, and pulse rate) to generate the model that performs better than other similar models developed using categorical variables. Compared with simpler approaches that try to make inferences of 5-year and 10-year risk models such as the model based on logistic regression analysis \[[@B53]\] and the CVD risk model using Kaplan-Meier and log-rank test \[[@B46]\], the proposed Cox risk model is more adequate and will avoid severe errors of underestimation or overestimation \[[@B22], [@B34]\]. Moreover, this model was developed based on a more substantial number of samples and events, suggesting a valid estimation of the real risk.

4.1. Comparison with Other CVD Risk Prediction Tools {#sec4.1}
----------------------------------------------------

The old version Framingham general CVD risk function \[[@B53]\] is useful for identifying persons at high risk of CVD, but it was based on a limited number of risk factors (serum cholesterol, SBP, smoking history, electrocardiogram, and glucose intolerance). The new Framingham laboratory-test-based formula \[[@B6]\] included HDL cholesterol in the risk function. The QRISK study investigators incorporated family history as a novel risk factor by the Framingham general formulas \[[@B8]\]. Although researchers have published risk scores \[[@B6], [@B8], [@B53]\] for predicting general CVDs, these functions did not include heart rate in the risk model.

Risk models formulated by using machine learning or data mining techniques have incorporated heart rate as a risk factor but tools that can predict CVD absolute risk are fewer. For example, a prediction tool \[[@B54]\] focuses on the classification of CVD event by employing the ANN and the Bayesian classifier based on heart rate variability. The diagnosis CVD model \[[@B27]\] categorizes the CVD risk as different levels but an absolute risk score cannot be obtained. Even though a supportive tool \[[@B19]\] will generate the estimate of a risk score, but the user can not know how many years the score is targeting.

Some equations only focused on specific CVD outcomes. The Europe SCORE project equations were developed for the fatal cardiovascular event \[[@B9]\]. These risk estimation tools \[[@B7], [@B14], [@B30]\] are just for coronary heart disease. Also, there are some risk models aiming stroke \[[@B16], [@B55]\]. Compared with these disease-specific models to estimate the risk of developing specific CVD outcomes, the present study generated a general CVD risk tool that could predict a global CVD risk as well as the risk of developing individual components.

Moreover, compared with the laboratory-based algorithms, the present research proposed a more straightforward way to estimate 10-year CVD risk based on risk factors. An individual can assess his or her CVD risk during an office visit or his monitoring of the combination of risk factors in the risk model, either manually or use some devices like wearable sensors.

4.2. Implication {#sec4.2}
----------------

The CVD risk prediction model could be implemented at the primary care for population analysis and identifying the high-risk individual. This would be a transformation in healthcare management of CVD at an individual as well as at a population level. However, with a small event size of diabetes, caution must be applied to the practice of this risk model. Even though we have used multiple imputation methods to impute the missing values for diabetes, the original feature of data in-balance, which decides that the imputed data frame for the "diabetes" might still have a data in-balance there. Advanced imputation methods need to be considered in the future for avoiding unexpected outcome caused by the diabetes data in-balance.

Our research aims to provide a CVD prediction model based on key risk factors, so that it can be used at the point-of-care for better and informed decision making. Thus, risk factors based on a clinical test such as total cholesterol, HDL cholesterol were not included, but some of these risk factors have a substantial effect on the development of CVD. We have provided a valid framework for creating a risk model using the Cox regression model; future work should consider risk factors not included in our model at this moment. Thus, expanding more predictors into the risk model is an important issue for future research.

5. Conclusion {#sec5}
=============

The proposed study devised a risk prediction model based on multivariable predictors. A novel risk factor "heart rate" was incorporated into this risk equation by conventional risk factors. A satisfying predictive ability with C-index (AUROC) of 0.71 was obtained, which ensures the accuracy of estimating risk scores. Compared with studies focusing on specific diseases, the proposed algorithm can be applied to measure the 10-year risk of CVD. Health care professionals, public health physicians, practice managers, and individuals can run the proposed model to quantify risk at a population level, during patient consultation and identify high-risk individuals for further preventive health care for the entire practice.

A. Exams in the Framingham Original Cohort Study Dataset {#secA}
========================================================

See [Table 7](#tab7){ref-type="table"}.

B. Data Summary for Samples {#secB}
===========================

See Tables [8](#tab8){ref-type="table"}[](#tab9){ref-type="table"}[](#tab10){ref-type="table"}--[11](#tab11){ref-type="table"}.

C. Computation of Absolute Risk {#secC}
===============================

Here, we take a specific subject to illustrate the process of risk score calculation. This sample is a 44-year-old man not having diabetes and hypertension. He has a systolic blood pressure of 120 mm Hg, pulse rate of 82 per minute, BMI of 26.38689413 kg/*m*~2~ and is a current smoker smoking 40 lapses per day, as shown in [Table 12](#tab12){ref-type="table"}.

The risk estimate based on the Cox model is calculated as follows: $$\begin{matrix}
{{\sum\limits_{i = 1}^{k}{\beta_{i}X_{i}}}2.083643\ast{\log\left( { 44} \right)} - 0.469719\ast 1} \\
{\mspace{2060mu} + 0.608864\ast{\log\left( { 26.386894} \right)} + 0.241461} \\
{\mspace{2060mu}\ast 0 + 1.682571\ast{\log\left( { 120} \right)} - 0.302090} \\
{\mspace{2060mu}\ast{\log\left( { 82} \right)} + 0.009669\ast 40 + 1.087501} \\
{\mspace{2060mu}\ast 0 = 16.518741} \\
\end{matrix}$$$$\begin{matrix}
{{\sum\limits_{i = 1}^{k}{\beta_{i}{\overset{-}{X}}_{i}}}2.083643\ast 3.768 - 0.469719\ast 1.548} \\
{\mspace{2060mu} + 0.608864\ast 3.230 + 0.241461\ast 0.1469} \\
{\mspace{2060mu} + 1.682571\ast 4.913 - 0.302090\ast 4.311} \\
{\mspace{2060mu} + 0.009669\ast 13.96 + 1.087501\ast 0.02001} \\
{= 16.518741} \\
\end{matrix}$$$$\begin{matrix}
{\hat{H\left( t \right)}{1 - \left\lbrack {S_{0}\left\lbrack t \right\rbrack} \right\rbrack}^{\exp{({{\sum_{i = 1}^{k}{\beta_{i}X_{i}}} - {\sum_{i = 1}^{k}{\beta_{i}{\overset{-}{X}}_{i}}}})}}} \\
{= 1 - 0.9027267^{\exp{({16518741 - 16.247045})}}} \\
{= 0.125658 \approx 12.57\%} \\
\end{matrix}$$

Data Availability
=================

The cardiovascular disease (CVD) data used to support the findings of this study were supplied by Framingham Heart Study-Cohort (FHS-Cohort) under license and so cannot be made freely available. Requests for access to these data should be made with Open BioLINCC Studies Group through this website <https://biolincc.nhlbi.nih.gov/studies/framcohort/>.

Additional Points
=================

The main contribution of the present study is developing a risk prediction model for early detection of CVD. More specifically, the contribution can be summarized in four major respects: firstly, a novel risk factor "heart rate" was identified as significant for the development of CVD; secondly, an CVD risk prediction model aiming for early detection of CVD was developed based on various risk factors; thirdly, an absolute risk score in 10 years of CVD can be calculated using this risk model; lastly, multiple forms of the risk estimation of CVD, namely risk equation and nomogram, were also developed.
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###### 

CVD event distribution in male and female.

           Count.   CVD Events   Age Range
  -------- -------- ------------ -----------
  Male     2294     1560         30 - 74
  Female   2785     1629         30 - 74
  Total    5079     3189         30 - 74

###### 

Description of candidate predictors.

  ----------------------------------------------------------------------------------------------------------------------------
  ORDERS   PREDICTORS                          UNITS                                                             TYPES
  -------- ----------------------------------- ----------------------------------------------------------------- -------------
  1        AGE                                 YEARS                                                             CONTINUOUS

                                                                                                                 

  2        SEX                                 0001 MALE\                                                        CATEGORICAL
                                               0002 FEMALE                                                       

                                                                                                                 

  3        BMI                                 KG/M2                                                             CONTINUOUS

                                                                                                                 

  4        HYPERTENSION                        0000 NEGATIVE\                                                    CATEGORICAL
                                               0001 TRANSIENT\                                                   
                                               0002 PERMANENT\                                                   
                                               0003 TYPE UNKNOWN\                                                
                                               0008 DOUBTFUL                                                     

                                                                                                                 

  5        HISTORY OF NERVOUS HEART            0000 NO\                                                          CATEGORICAL
                                               0001 YES, DEFINITE                                                

                                                                                                                 

  6        HISTORY OF PERICARDITIS             0000 NO\                                                          CATEGORICAL
                                               0001 YES, DEFINITE                                                

                                                                                                                 

  7        HISTORY OF OTHER CVD                0000 NO\                                                          CATEGORICAL
                                               0001 YES, DEFINITE                                                

                                                                                                                 

  8        PREMATURE BEATS                     0000 NO\                                                          CATEGORICAL
                                               0001 YES, DEFINITE\                                               
                                               0002 YES, DOUBTFUL                                                

                                                                                                                 

  9        HISTORY OF ATRIOVENTRICULAR BLOCK   0000 NO\                                                          CATEGORICAL
                                               0001 YES, DEFINITE\                                               
                                               0002 YES, DOUBTFUL                                                

                                                                                                                 

  10       HISTORY OF RHEUMATIC FEVER          0000 NONE\                                                        CATEGORICAL
                                               0001 YES\                                                         
                                               0008 DOUBTFUL                                                     

                                                                                                                 

  11       HISTORY OF ALLERGY OR ASTHMA        0000 NEGATIVE\                                                    CATEGORICAL
                                               0001 ALLERGY, ALONE\                                              
                                               0002 BRONCHIAL ASTHMA, ALONE, 0003 ALLERGY AND ASTHMA, TOGETHER   

                                                                                                                 

  12       HISTORY OF THYROID DISEASE          0000 NEGATIVE\                                                    CATEGORICAL
                                               0001 HYPERTHYROID ONLY\                                           
                                               0002 HYPOTHYROID ONLY                                             

                                                                                                                 

  13       HISTORY OF SUBACUTE ENDOCARDITIS    0000 NO\                                                          CATEGORICAL
                                               0001 YES                                                          

                                                                                                                 

  14       BLOOD PRESSURE SYSTOLIC             MM HG                                                             CONTINUOUS

                                                                                                                 

  15       BLOOD PRESSURE DIASTOLIC            MM HG                                                             CONTINUOUS

                                                                                                                 

  16       CIGARETTES PER DAY                  LAPSE, FORM 8/50                                                  CONTINUOUS

                                                                                                                 

  17       CIGARS PER DAY                      LAPSE, FORM 8/50                                                  CONTINUOUS

                                                                                                                 

  18       PIPERS PER DAY                      LAPSE, FORM 8/50                                                  CONTINUOUS

                                                                                                                 

  19       PULSE RATE                          PER MINUTE                                                        CONTINUOUS

                                                                                                                 

  20       DIABETES                            0000 NO\                                                          CATEGORICAL
                                               0001 YES, DEFINITE                                                
  ----------------------------------------------------------------------------------------------------------------------------

###### 

Summary statistics for risk factors used in risk model.

  Predictors                Variables   Min.    1st Qu.   Median   Mean     3rd Qu.   Max.
  ------------------------- ----------- ------- --------- -------- -------- --------- -------
  AGE                       Age         28      37        44       44.15    51        74
  SEX                       Sex         1       1         2        1.548    2         2
  BMI                       Bmi         14.12   22.66     25.17    25.61    27.92     56.68
  HYPERTENSION              Hyp         0       0         0        0.147    0         1
  BLOOD PRESSURE SYSTOLIC   Bps         84      122       136      138.6    150       270
  CIGARETTES PER DAY        Cgrpd       0       5         20       16.26    20        60
  PULSE RATE                Pr          37      67        75       75.61    83        170
  DIABETES                  Dia         0       0         0        0.0197   0         1

###### 

Regression coefficients and hazard ratios in risk model.

  Predictors                Variables    coef*∗*     Hazard Ratio   lower .95   upper .95
  ------------------------- ------------ ----------- -------------- ----------- -----------
  AGE                       log of age   2.083643    8.033686       6.4082      10.0716
  SEX                       sex          -0.469719   0.625178       0.5787      0.6754
  BMI                       log of bmi   0.608864    1.838342       1.4368      2.3521
  HYPERTENSION              hyp          0.241461    1.273108       1.1342      1.429
  BLOOD PRESSURE SYSTOLIC   log of bps   1.682571    5.37937        3.7938      7.6277
  CIGARETTES PER DAY        cgrpd        0.009669    1.009716       1.0065      1.013
  PULSE RATE                log of pr    -0.30209    0.739271       0.5879      0.9297
  DIABETES                  dia          1.087501    2.96685        2.3244      3.7869

*∗* Estimated regression coefficient.

###### 

Baseline hazard and survival at 10 years.

                               Covariates at mean value   Covariates equal to zero
  ---------------------------- -------------------------- --------------------------
  Baseline hazard estimate     0.1023354                  0.001863652
  Baseline survival estimate   0.9027267                  0.9981381

###### 

Data summary for samples in the longitudinal validation.

  Samples    Gender   CVD   Diabetes
  ---------- -------- ----- ----------
  Sample 1   Male     *✘*   *✘*
  Sample 2   Male     ✓     ✓
  Sample 3   Female   *✘*   *✘*
  Sample 4   Female   ✓     ✓

###### 

Exams in the Framingham Original Cohort study data set.

  Exams       Exam Date Range   Age Range   Mean Age   Attendees
  ----------- ----------------- ----------- ---------- -----------
  Exam 1      1948 - 1953       28 - 74     44         5209
  Exam 2      1950 - 1955       31 - 65     46         4792
  Exam 3      1952 - 1956       32 - 67     48         4416
  Exam 4      1954 - 1958       34 - 69     50         4541
  Exam 5      1956 - 1960       37 - 70     52         4421
  Exam 6      1958 - 1963       38 - 72     54         4259
  Exam 7      1960 - 1964       40 - 74     55         4191
  *Exam 8*    *1962 - 1966*     *42 - 76*   *57*       *4030*
  *Exam 9*    *1964 - 1968*     *44 - 78*   *59*       *3833*
  *Exam 10*   *1966 - 1970*     *46 - 80*   *61*       *3595*
  *Exam 11*   *1968 - 1971*     *49 - 81*   *62*       *2955*
  *Exam 12*   *1971 - 1974*     *50 - 83*   *64*       *3261*
  *Exam 13*   *1972 - 1976*     *53 - 85*   *66*       *3133*
  Exam 14     1975 - 1978       55 - 88     68         2871
  Exam 15     1977 - 1979       57 - 89     69         2632
  Exam 16     1979 - 1982       59 - 91     70         2351
  Exam 17     1981 - 1984       61 - 93     72         2179
  Exam 18     1983 - 1985       63 - 94     74         1825
  Exam 19     1985 - 1988       65 - 96     75         1541
  Exam 20     1986 - 1990       67 - 97     77         1401
  Exam 21     1988 - 1992       69 - 99     79         1319
  Exam 22     1990 - 1994       72 - 101    80         1166
  Exam 23     1992 - 1996       73 - 101    81         1026
  Exam 24     1995 - 1998       76 - 103    83         831
  Exam 25     1997 - 1999       78 - 104    84         703
  Exam 26     1999 - 2001       79 - 103    86         558
  Exam 27     2002 - 2003       82 - 104    87         414
  Exam 28     2004 - 2005       84 - 104    89         303
  Exam 29     2006 - 2007       85 - 102    91         218
  Exam 30     2008 - 2010       88 - 102    92         141
  Exam 31     2010 - 2011       90 - 99     92         91
  Exam 32     2012 - 2014       93 - 106    96         40

###### 

Exam data for Sample 1: male without CVD.

  Exams     age   bmi         bps   pr   cgrpd   trt   hyp   dia   smk
  --------- ----- ----------- ----- ---- ------- ----- ----- ----- -----
  Exam 8    44    26.386894   120   82   40      0     0     0     1
  Exam 9    45    26.826676   120   80   0       0     0     0     0
  Exam 10   47    27.467643   118   70   20      0     0     0     1
  Exam 11   49    28.222249   110   76   44      0     0     0     1
  Exam 12   52    28.675012   110   80   50      0     0     0     1

###### 

Exam data for Sample 2: male with CVD and diabetes.

  Exams     age   bmi         bps   pr   cgrpd   trt   hyp   dia   smk
  --------- ----- ----------- ----- ---- ------- ----- ----- ----- -----
  Exam 8    45    27.74258    132   83   20      0     0     0     1
  Exam 9    47    26.26118    124   80   20      0     0     0     1
  Exam 10   49    27.664352   130   78   20      0     1     0     1
  Exam 11   51    27.121914   130   90   20      0     1     0     1
  Exam 12   53    24.816551   122   82   20      0     0     1     1

###### 

Exam data for Sample 3: female without CVD.

  Exams     age   bmi         bps   pr   cgrpd   trt   hyp   dia   smk
  --------- ----- ----------- ----- ---- ------- ----- ----- ----- -----
  Exam 8    44    20.776333   110   70   20      0     0     0     1
  Exam 9    46    20.265439   120   70   20      0     0     0     1
  Exam 10   48    22.312012   118   73   20      0     0     0     1
  Exam 11   50    21.797119   114   82   20      0     0     0     1
  Exam 12   52    21.797119   130   76   20      0     0     0     1

###### 

Exam data for Sample 4: female with CVD and diabetes.

  Exams     age   bmi         bps   pr   cgrpd   trt   hyp   dia   smk
  --------- ----- ----------- ----- ---- ------- ----- ----- ----- -----
  Exam 8    46    21.793044   130   65   3       0     1     0     1
  Exam 9    48    21.967388   170   75   16      0     1     0     1
  Exam 10   50    22.494583   140   60   8       0     1     0     1
  Exam 11   53    22.31746    140   63   8       0     1     0     1
  Exam 12   54    23.380197   160   58   2       1     1     1     1

###### 

Data summary for the subject 15018644.

  PREDICTORS                  VALUES        UNITS
  --------------------------- ------------- ------------
  AGE                         44            YEARS
  SEX                         1             MALE
  BMI                         26.38689413   KG/M2
  HYPERTENSION                0             NO
  TREATMENT OF HYPERTENSION   0             NO
  BLOOD PRESSURE SYSTOLIC     120           MM HG
  CIGARETTES PER DAY          40            LAPSE
  SMOKING                     1             YES
  PULSE RATE                  82            PER MINUTE
  DIABETES                    0             NO
  *COX MODEL RISK*            *12.57*%      
  *FHS MODEL RISK*            *11.86*%      

[^1]: Academic Editor: Gerardo E. Guillén Nieto
